(JRUD) JPMorgan s (Ireland) ICAV - Ratings and Ratios
Equity ETF, US Large-Cap, UCITS, XETRA, US Equity, JRUD, JPMorgan ETF
Description: JRUD JPMorgan s (Ireland) ICAV
The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - USD (inc) is an exchange-traded fund that tracks the Morningstar US Large-Mid NR USD index, providing investors with exposure to a broad range of large-cap and mid-cap US stocks. This ETF is listed on the XETRA exchange under the ticker symbol JRUD.
By leveraging JPMorgans research capabilities, this ETF aims to enhance returns by tilting towards stocks with favorable research ratings, while maintaining a diversified portfolio. The funds investment strategy is designed to balance risk and potential returns, making it a suitable option for investors seeking US equity exposure.
Analyzing the
Considering the
Our forecast, based on both technical and fundamental analysis, suggests that JRUD may experience a moderate uptrend in the coming weeks, driven by its research-enhanced index methodology and the overall US equity market performance. However, investors should remain cautious of potential market volatility and adjust their strategies accordingly. A break above the 52-week high of 54.49 could signal a stronger uptrend, while a decline below the 52-week low of 41.73 may indicate a more significant downturn.
Additional Sources for JRUD ETF
JRUD ETF Overview
Market Cap in USD | 7,131m |
Category | US Large-Cap Blend Equity |
IPO / Inception | 2019-12-16 |
JRUD ETF Ratings
Growth Rating | 66.9 |
Fundamental | - |
Dividend Rating | 27.4 |
Rel. Strength | -9.45 |
Analysts | - |
Fair Price Momentum | 56.84 EUR |
Fair Price DCF | - |
JRUD Dividends
Dividend Yield 12m | 0.56% |
Yield on Cost 5y | 1.13% |
Annual Growth 5y | -4.53% |
Payout Consistency | 94.2% |
Payout Ratio | % |
JRUD Growth Ratios
Growth Correlation 3m | 76.4% |
Growth Correlation 12m | 10.5% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 15.18% |
CAGR/Max DD 5y | 0.65 |
Sharpe Ratio 12m | 0.39 |
Alpha | -9.24 |
Beta | 0.789 |
Volatility | 10.22% |
Current Volume | 2k |
Average Volume 20d | 2.3k |
As of July 04, 2025, the stock is trading at EUR 49.64 with a total of 1,980 shares traded.
Over the past week, the price has changed by +2.15%, over one month by +2.22%, over three months by +8.80% and over the past year by +3.96%.
Yes. Based on ValueRay's Analyses, JPMorgan s (Ireland) ICAV (XETRA:JRUD) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.88 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JRUD is around 56.84 EUR . This means that JRUD is currently undervalued and has a potential upside of +14.5% (Margin of Safety).
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
According to our own proprietary Forecast Model, JRUD JPMorgan s (Ireland) ICAV will be worth about 65.6 in July 2026. The stock is currently trading at 49.64. This means that the stock has a potential upside of +32.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 65.6 | 32.1% |